 |
 |
Biocon posts good Q2 result; shares up
31 October 2012
|
|
|
|
Biocon among top 20 employers in sector: survey
25 September 2012
|
|
|
Biocon plans merger with biopharma subsidiary
18 July 2012
|
| | |
|
|
Abbott collaborates with Syngene to open first nutrition research centre in India
05 May 2012
|
|
|
Pfizer terminates $350-mn insulin marketing deal with Biocon
13 March 2012
|
|
|
Biocon arm Clinigene in pact with US company for speciality biomarkers
21 December 2011
|
|
|
Biocon posts Rs86 crore net profit for quarter ended September
22 October 2011
|
|
|
Biocon to set biopharmaceutical plant, R&D centre in Malaysia
12 September 2011
|
|
|
Biocon clinical arm, Spaulding of US in clinical trial partnership
22 August 2011
|
|
|
New cancer facility opens at Mazumdar-Shaw Cancer Center, Bangalore
07 May 2011
|
|
|
Biocon to divest stake in Germany's AxiCorp
28 April 2011
|
|
|
Biocon to invest $161 million in Malaysian biotech firm
28 October 2010
|
|
|
Biocon second-quarter bottomline up 20 per cent Y-O-Y
22 October 2010
|
|
|
Pfizer, Biocon enter into deal for biosimilar insulin
19 October 2010
|
|
|
Havana's CIM S A to collaborate in immunology research with Biocon
27 September 2010
|
|
|
Biocon net profit up 33 per cent
24 July 2010
|
|
|
Biocon arm to buy out CIMAB's 49 per cent stake in Biocon Biopharma
05 April 2010
|
|
|
Biocon arm Syngene, Endo Pharma tie up for biological cancer drug
22 March 2010
|
|
|
India should focus on affordable innovation: Kiran Mazumdar-Shaw
08 March 2010
|
|
|
Biotech sector set to grow by leaps and bounds, says Biocon chief
20 January 2010
|
|
|
Biocon, HCG hospitals team up to fight cervical cancer
10 December 2009
|
|
|
Hunduja's Gulf Oil sells IDL Specialty Chemicals to Biocon
01 October 2009
|
|
|
Biocon in hybrid drug development pact with Amylin
11 September 2009
|
|
|
Biocon Q1 net profit rises four-fold to Rs57 crore
23 July 2009
|
|
|
Biocon, Mylan tie up for generic biologic drugs
29 June 2009
|
|
|
Biocon's Kiran Mazumdar Shaw to receive Nikkei Asia Prize
11 May 2009
|
|
|
Biocon’s Q4 profit plummets by 62 per cent
28 April 2009
|
|
|
Biocon arm Syngene in R&D pact with DuPont Crop Protection
09 March 2009
|
|
|
Biocon ranked seventh top biotech employer globally
22 September 2008
|
|
|
Biocon says its oral insulin is good for Type 2 diabetes
08 September 2008
|
|
|
Biocon is global Top 20 biotechnology company
17 July 2008
|
|
|
Biocon launches India's first pre-filled syringes
04 June 2008
|
|
|
Biocon close to finalising AxiCorp acquisition; establishes cardiology division
22 April 2008
|
|
|
Biocon eyes more acquisitions overseas
27 February 2008
|
|
|
Biocon to acquire European pharma distributor AxiCorp to enter Europe
11 February 2008
|
|
|
Biocon cancer drug wins BioSpectrum 'Product of the Year' award
22 December 2007
|
|
|
Biocon plans Rs 100 crore annual research spend
31 October 2007
|
|
|
Drug Controller-General approves Biocon - Abraxis BioScience breast cancer drug Abraxane
19 October 2007
|
|
|
Biocon in pact with Abraxis to market breast cancer drug Abraxane in India
09 August 2007
|
|
|
Biocon enters into JV with Neopharma of UAE
30 July 2007
|
|
|
Abraxis BioScience to license biosynthetic cancer drug from Biocon
19 July 2007
|
|
|
Biocon divests enzymes for $115 million, enters into exclusive deal for bioinsulin
18 July 2007
|
|
|
Biocon signs MoU with Australia's Deakin University
08 June 2007
|
|
|
Biocon eyes more research outsourcing deals
22 March 2007
|
|
|
Biocon arm to set up dedicated R&D facility for Bristol-Myers Squibb
14 March 2007
|
|
|
Biocon to invest Rs 1,000 crore in Vizag SEZ
17 February 2007
|
|
|
Biocon grants marketing license for cancer drug in Pakistan
18 January 2007
|
|
|
Biocon in joint venture with Abu Dhabi-based Neopharma
06 January 2007
|
|
|
Biocon subsidiary Clinigene completes phase-IV study on new generation insulin
26 December 2006
|
|
|
Three Indians in Fortune''s `Global Power 50'' list
of businesswomen
11 October 2006
|
|
|
Biocon launches cancer anti-body drug BioMab-EGFR
18 September 2006
|
|
|
Biocon's Syngene International and Sweden's Innate Pharma to develop virulence blockers
04 September 2006
|
|
|
Biocon Biopharmaceuticals’ new biologics facility
17 April 2006
|
|
|
Biocons' Kiran Mazumdar-Shaw wins Wharton-Infosys business transformation awards
07 January 2006
|
|
|
The Biocon story
07 May 2004
|
|
|
Biocon issue oversubscribed
12 March 2004
|
|
|
Biocon issue will sail through : Kiran Mazumdar
03 March 2004
|
|
|
Biocon IPO opens on March 11
28 February 2004
|
|
|
Grey
Worldwide India wins the accounts of Tetra Pak, Biocon
12 March 2003
|
|
|
Biocon group restructuring
27 December 1999
|
